School of Medicine
Showing 441-450 of 529 Results
Darvin Scott Smith
Casual - Academic Staff, Microbiology and Immunology
Bio Darvin (Scott) Smith graduated in biochemistry from Bowdoin College in Maine and went on to study tropical public health at Harvard School of Public health before attending medical school in his home state of Colorado, where he grew up. He worked on developing diagnostic tests and epidemiology (Leishmania and Onchocerciasis) in Cali Colombia on a Fulbright scholarship before finally moving to California where he completed residency at Stanford Medical School, then a Fellowship in Infectious Disease & Geographic Medicine. He now serves as Chief of the Dept of Infectious Disease at Kaiser Permanente in Redwood City California, and he teaches several classes at Stanford.
Scott volunteers as a community neighborhood network lead in Hillsborough and works with international disaster response to vector borne disease threats as a clinical lead for MENTOR-Initiative around the world (Indonesia, Myanmar, Tanzania, Kenya, Haiti, Thailand). Scott enjoys gardening, sustainable household development, photography and wants to do a triathalon...
Biodesign Executive Assistant, School of Medicine - MDRP'S - Biodesign Program
Current Role at Stanford Executive Assistant to
Thomas M Krummel, MD, Stanford Biodesign Co-Director
Todd Brinton, MD, Stanford Biodesign Innovation Fellowship Director
James H. Clark Center | 318 Campus Drive, Rm E100, MC5428 | Stanford, CA 94305
Director, HTBC, Chemical and Systems Biology Operations
Current Role at Stanford Director, High-Throughput Bioscience Center
The High-Throughput Bioscience Center's mission is to provide researchers at Stanford with the ability to run high-throughput chemical, siRNA, cDNA, and high-content screens for the purpose of drug and/or target discovery. The HTBC is a Stanford University School of Medicine core facility and was created in 2003 by the Department of Chemical and Systems Biology (formerly Molecular Pharmacology). The HTBC is a shared resource (Bioscience Screening Facility) for the Stanford Cancer Institute (more info), the Digestive Disease Center (Chemical Genomics Core), and the NIH Clinical and Translational Science Award (Spectrum).
Research approaches that were previously done exclusively in industry are now being used in academia to advance basic research. This high-throughput screening (HTS) laboratory allows Stanford researchers and others to discover novel modulators of targets that otherwise would not be practical in industry. The center incorporates instrumentation (purchased with NCRR NIH Instrumentation grant numbers S10RR019513 and S10RR026338), databases, compound libraries, and personnel whose previous sole domains were in industry. Among our instrumentation are a Molecular Devices ImageXpress Micro High-Content fluorescence microplate imager, with live cell and phase contrast/brightfield options, a Caliper Life Sciences SciClone ALH3000 and an Agilent Bravo microplate liquid handler, and the Molecular Devices Analyst GT and FlexStation II 384 and Tecan Infinite M1000 PRO fluorescence, luminescence and absorbance multimode microplate readers. We have over 135,000 small molecules for compound screens, 15,000 cDNAs for genomic screens, and the siARRAY whole human genome siRNA library from ThermoFisher Scientific (formerly Dharmacon) targeting 21,000 genes.
The HTBC is located in CCSR Room 0133-North Wing, between the Transgenic Mouse Facility, the Immune Monitoring Core, and the Stanford Functional Genomics Facility.
Deputy Director, Precision Health and Integrated Diagnostics Center, Rad/Molecular Imaging Program at Stanford
Bio Dr. Spitler is the Deputy Director of the Precision Health and Integrated Diagnostics Center at Stanford University. He completed his Post Doctorial Research Fellowship (SCIT) at Stanford University School of Medicine, conducting research in the developing field of Magnetogenetics for remote controlled cellular reprogramming and developed smart MRI cell tracking tools for oncology cell tracking studies. He has designed numerous biological models, synthetic biology approaches and worked on the development of new technologies in a number of scientific areas ranging from medical devices to gene therapy. Prior to his position at Stanford, Dr. Spitler received his Ph.D. in Cellular and Developmental Biology at the Beckman Laser Institute at the University of California, Irvine. His research at the Beckman Laser Institute included developing and characterizing new nitric oxide-based drugs, laser, and LED-based multimodal wound healing therapies some of which are currently being used in the clinic as a result of his work.
Dr. Spitler received his Bachelor’s of Science degree in Molecular Cell and Developmental Biology from the University of California, Santa Cruz, where he worked in the area of structural biology. Over the past two decades he has held a number of academic and industrial positions and has served as an advisor or advisory board member for a number of Bay Area companies. Dr. Spitler is the recipient of the Stanford Cancer Imaging Fellowship Training Award, RSL Innovation Challenge Award, the Biophotas Research Fellowship, and the Stanford Center for Biomedical Imaging Achievement Award.